Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer

The Journal of Pathology(2023)10.1002/path.6165Source: DataRank Database

Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer is a research paper published in The Journal of Pathology (2023). On theSindex it has a DataRank of 0. It has been cited 51 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access51 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (91 grants)Impact (FWCI 5.48)OA: bronzeTopics (65)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (100)

Glenn Broeckx ORCID,Chowdhury Arif Jahangir ORCID,Sara Verbandt ORCID,Rajarsi Gupta ORCID,Jeppe Thagaard ORCID

Live enrichment

PubMed:37608771 PMC:PMC11288334 OpenAlex:https://openalex.org/W4386084933

DOD Peer Reviewed Cancer Research Program

Grant: W81XWH‐21‐1‐0345

DOD Peer Reviewed Cancer Research Program

Grant: W81XWH‐18‐1‐0404

DOD Peer Reviewed Cancer Research Program

Grant: W81XWH‐21‐1‐0160

National Institutes of Health

Grant: P50 CA247749 01

National Institutes of Health

Grant: R37 CA225655

National Institutes of Health

Grant: CA196521

National Institutes of Health

Grant: CA263705

National Institutes of Health

Grant: DK124165

National Institutes of Health

Grant: CA224319

National Institutes of Health

Grant: P50 CA116201

National Health and Medical Research Council

Grant: GNT1193630

Cancer Research UK

Grant: KCL‐BCN‐Q3

Cancer Research UK

Grant: CRUK/07/012

Japan Society for the Promotion of Science

Grant: 21K06909

National Cancer Institute

Grant: 1U54CA254566‐01

National Cancer Institute

Grant: 1U01CA248226‐01

National Cancer Institute

Grant: 1U01CA239055‐01

National Cancer Institute

Grant: R01CA257612‐01A1

National Cancer Institute

Grant: R01CA220581‐01A1

National Cancer Institute

Grant: R01CA216579‐01A1

National Cancer Institute

Grant: R01CA208236‐01A1

National Cancer Institute

Grant: R01CA202752‐01A1

National Cancer Institute

Grant: R01CA249992‐01A1

National Cancer Institute

Grant: R01CA26820701A1

National Cancer Institute

Grant: U01CA269181

National Cancer Institute

Grant: R01CA268287A1

National Cancer Institute

Grant: UH3CA225021

National Cancer Institute

Grant: U24CA215109

National Institute of Biomedical Imaging and Bioengineering

Grant: 1R43EB028736‐01

DOD Prostate Cancer Research Program

Grant: W81XWH‐20‐1‐0851

Engineering and Physical Sciences Research Council

Grant: EP/W02909X/1

Causal Modelling with Graph Neural Networks for Personalised Medicine in Computational Pathology

Breast Cancer Research Foundation

Grant: 17‐194

Breast Cancer Research Foundation

Grant: APP ID: BCRF‐21‐102]

Ministerie van Volksgezondheid, Welzijn en Sport

Grant: 22‐161

Agence Nationale de la Recherche

Grant: ANR‐19‐P3IA‐0001

Cancer Research UK

Grant: C45982/A21808

NCI NIH HHS

Grant: R01 CA257612

NCI NIH HHS

Grant: R33 CA263705

NCI NIH HHS

Grant: U01 CA239055

NIDDK NIH HHS

Grant: U01 DK124165

NIBIB NIH HHS

Grant: R43 EB028736

NCI NIH HHS

Grant: U54 CA254566

NCI NIH HHS

Grant: P50 CA247749

NCI NIH HHS

Grant: R01 CA202752

NCI NIH HHS

Grant: U24 CA224319

NCI NIH HHS

Grant: R01 CA208236

NHLBI NIH HHS

Grant: R01 HL158071

BLRD VA

Grant: I01 BX004121

NCI NIH HHS

Grant: R01 CA216579

NHLBI NIH HHS

Grant: R01 HL151277

NCI NIH HHS

Grant: R01 CA220581

NCI NIH HHS

Grant: R01 CA249992

NCI NIH HHS

Grant: R01 CA268287

NCI NIH HHS

Grant: U01 CA248226

Cancer Research UK

Grant: KCL-BCN-Q3

NCI NIH HHS

Grant: P30 CA196521

NCI NIH HHS

Grant: R01 CA268207

National Institutes of Health

Grant: 3U24CA215109-02S1

TCIA Sustainment and Scalability - Platforms for Quantitative Imaging Informatics in Precision Medicine

National Institutes of Health

Grant: 1U54CA254566-01

Lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging

National Institutes of Health

Grant: 5U01DK124165-02

Characterizing and predicting colitis in immune checkpoint blockade-treated cancer patients

French National Research Agency (ANR)

Grant: ANR-17-CONV-0005

National Institutes of Health

Grant: 5R01CA216579-03

Computerized Histologic Risk Predictor (CHiRP) for Early Stage Lung Cancers

National Institutes of Health

Grant: 5R01CA202752-05

Computerized histologic image predictor of cancer outcome

National Institutes of Health

Grant: 1R01CA257612-01A1

Novel Radiomics for Predicting Response to Immunotherapy for Lung Cancer

National Institutes of Health

Grant: 4UH3CA225021-03

Methods and Tools for Integrating Pathomics Data into Cancer Registries

National Institutes of Health

Grant: 5U01CA269181-03

An AI-enabled Digital Pathology Platform for Multi-Cancer Diagnosis, Prognosis and Prediction of Therapeutic Benefit

Science Foundation Ireland

Grant: 15/IA/3104

Optimal Management of Gender-Specific Cancers via Efficient Use of Protein Profiling, Digital Pathology and Systems Medicine Tools (OPTi-PREDICT)

National Institutes of Health

Grant: 1P30CA196521-01

Mouse Genetics

National Institutes of Health

Grant: 3P50CA247749-05S1

MSK SPORE in Genomic Instability in Breast Cancer

National Institutes of Health

Grant: 5U24CA224319-04

High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy Trials

National Institutes of Health

Grant: 5P50CA116201-08

Career Development (Ingle)

Higher Education Authority

Grant: unidentified

unidentified

National Institutes of Health

Grant: 1R01CA249992-01A1

Oral Cavity Quantitative Histomorphometric Risk Classifier (OHbIC) in Oral Cavity Squamous Cell Carcinoma (OC-SCC)

Science Foundation Ireland

Grant: 18/SPP/3522

Precision Oncology Ireland

National Institutes of Health

Grant: 1R33CA263705-01

PRIMAVO: Interactive exploration of cancer patient precision immune monitoring data in clinical trials

European Commission

Grant: 860627

CLoud ARtificial Intelligence For pathologY

National Health and Medical Research Council (NHMRC)

Grant: 1193630

Translating molecular pathology into cancer diagnostics

National Institutes of Health

Grant: 5R37CA225655-08

Illuminating the evolutionary history of colorectal cancer metastasis: basic principles and clinical applications

French National Research Agency (ANR)

Grant: ANR-19-P3IA-0001

National Institutes of Health

Grant: 1R43EB028736-01

A Study to Validate and Improve an Automated Image Analysis Algorithm to Detect Tuberculosis in Sputum Smear Slides

National Institutes of Health

Grant: 5R01CA220581-05

Quantitative Histomorphometric Risk Classifier (QuHbIC) in HPV + Oropharyngeal Carcinoma

Breast Cancer Now

Fondation ARC pour la Recherche sur le Cancer

Svenska Sällskapet för Medicinsk Forskning

Higher Education Authority

Peter MacCallum Cancer Centre

Irish Cancer Society

AstraZeneca

U.S. Department of Veterans Affairs

KU Leuven

U.S. Department of Defense

FWCI

5.48

Citation Percentile

1.0%

Citation Trend

2015

2023

2024

2025

2026

bronzeLicense: Wiley Online Library User Agreement

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/path.6165

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/path.6165

publisherhttps://pathsocjournals.onlinelibrary.wiley.com/doi/am-pdf/10.1002/path.6165

publisherhttps://pathsocjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/path.6165

journalhttps://doi.org/10.1002/path.6165

Fields of Study

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesEsophageal Cancer Research and Treatment03 medical and health sciences0302 clinical medicineHumansColonic NeoplasmsBiomarkersBenchmarkingLymphocytes, Tumor-InfiltratingSpatial AnalysisTumor Microenvironment

MeSH Terms

Colonic NeoplasmsHumansBiomarkersLymphocytes, Tumor-InfiltratingBenchmarkingTumor MicroenvironmentSpatial Analysis

Keywords

Breast cancerOncologyBiomarkerMedicineInfiltration (HVAC)Immune systemInternal medicineCancerImmunologyBiologyGeographySpatial statisticsSpatial heterogeneityTumor infiltrating lymphocytesTILImmunoscoreMultispectral ImmunofluorescenceStil ScoreSDG-03: Good health and well-beingStromal tumor infiltrating lymphocytes (sTIL) score610Radboud University Medical Center[SDV.CAN]Life Sciences [q-bio]/CancerRadboudumc 17: Women's cancers PathologyTumor infiltrating lymphocytes (TIL)Radboudumc 9: Rare cancers PathologyLymphocytes, Tumor-Infiltrating[SDV.CAN] Life Sciences [q-bio]/Cancer616Tumor MicroenvironmentHumansVDP::Medisinske Fag: 700LymphocytesTumor-InfiltratingSpatial AnalysissTILs score620name=SDG 3 - Good Health and Well-beingBenchmarkingRadboudumc 17: Women's cancers Medical ImagingColonic Neoplasms/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingHuman medicinetumor infiltrating lymphocytes.TILSBiomarkers

Sustainable Development Goals

SDG 0: Partnerships for the goals